Uehara, Hiroki
Nagai, Toshiyuki https://orcid.org/0000-0002-1043-0608
Sasaki, So
Tamano, Kento
Tamura, Toshifumi
Takahashi, Akinori
Hamaya, Takeshi
Mori, Yuki
Yasui, Yutaro
Takenaka, Sakae
Tsuneta, Satonori
Ishizaka, Suguru
Kobayashi, Yuta
Tada, Atsushi
Temma, Taro
Kamiya, Kiwamu
Anzai, Toshihisa
Funding for this research was provided by:
Japan Society for the Promotion of Science (23K07174)
Article History
Received: 9 October 2025
Accepted: 17 December 2025
First Online: 21 January 2026
Declarations
:
: Dr. Nagai received research grants from Pfizer Inc., Mitsubishi Tanabe Pharma Corp., and Roche Diagnostics K.K. and honoraria from Kyowa Kirin Co., Ltd., Bayer Yakuhin, Ltd., Viatris Inc., Nippon Boehringer Ingelheim Co., Ltd., and Bristol-Myers Squibb K.K. Dr. Anzai received a research grant from Daiichi Sankyo Co., Ltd.; scholarship funds from Biotronik Japan Co., Ltd., Medtronic Japan Co., Ltd., Win International Co., Ltd., Medical System Network Co., Ltd., and Hokuyaku Takeyama Holdings, Inc.; and honoraria from Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., Boehringer Ingelheim Japan Co., Ltd., Bayer’s Pharmaceuticals Co., Ltd., and Bristol-Myers Squibb Co., Ltd. The remaining authors declare no conflicts of interest.